Clinical trials: Acute Gastritis
Acute Gastritis, Chronic Gastritis
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
The purpose of study is to confirm the efficacy of DWP14012 X mg QD, DWP14012 Y mg BID compared to placebo in patients with Acute or Chronic Gastritis
- Trial name
- NCT04341454
- Testing
- DWP14012 X mg, DWP14012 Y mg
- Where
- South Korea
- Volunteers
- 327 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Gastritis Acute, Gastritis Chronic
To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient
A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1903 in Patients with Gastritis
- Trial name
- NCT05163756
- Testing
- DW1903, DW1903-R1
- Where
- South Korea
- Volunteers
- 332 people
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis.
- Trial name
- NCT01817556
- Testing
- Stillen Tab., Mucosta Tab.
- Where
- South Korea
- Volunteers
- 258 people
- Sponsor
- Dong-A ST Co., Ltd.
Gastritis Acute, Gastritis Chronic
To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients
Evaluate the Efficacy and Safety of DW1401 versus Stillen tab. in Patients with Acute or Chronic Gastritis
- Trial name
- 2 (NCT03443804)
- Testing
- Test(DW1401), Reference(Stillen tab.)
- Volunteers
- 462 people
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
Chronic Pancreatitis, Inflammatory Bowel Diseases
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
This is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings that are published in the medical literature affect…
- Conditions
- Chronic Pancreatitis, Inflammatory Bowel Diseases, Hepatitis, NASH - Nonalcoholic Steatohepatitis
- Trial name
- GREAT1 (NCT04306939)
- Testing
- venipuncture, Questionnaires, Additional Sample Collections
- Where
- United States
- Volunteers
- 120,000 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
Erosive Gastritis
Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis
The purpose of this study is to Assess the Efficacy and Safety of SK-MS10 in subjects With acute and chronic gastritis.
- Trial name
- NCT01578811
- Testing
- SK-MS10
- Where
- South Korea
- Volunteers
- 102 people
- Sponsor
- SK Chemicals Co., Ltd.
Acute Gastritis, Gastric Ulcer
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
This is a self-controlled, open, multiple-center clinical trial.
- Trial name
- NCT01190657
- Testing
- Selbex
- Where
- 26 sites in China
- Volunteers
- 1,184 people
- Sponsor
- Eisai Co., Ltd.
Gastritis, Acute Gastritis
Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis
This Phase 4, multicenter, randomized, double-blind, active-controlled, non-inferiority study aims to evaluate the non-inferiority of Stoem Tab. compared to Stillen Tab.
- Conditions
- Gastritis, Acute Gastritis, Chronic Gastritis
- Trial name
- NCT07631065
- Testing
- Stillen Tab., Sto M Tab.
- Volunteers
- 470 people
- Sponsor
- Mather's Pharm. Co., Ltd.
Acute Gastritis, Chronic Gastritis
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.
- Trial name
- NCT02356679
- Testing
- Eupasidin-s Tab, Stillen Tab.
- Where
- 10 sites in South Korea
- Volunteers
- 230 people
- Sponsor
- Chong Kun Dang Pharmaceutical
Gastritis
Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
This study aims to evaluate the efficacy of Fexuclue tablets in improving gastrointestinal symptoms based on patient-reported outcomes (PROs), by comparing assessments before and after treatment.
- Trial name
- NCT06948487
- Where
- South Korea
- Volunteers
- 12,000 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Acute Gastritis, Chronic Gastritis
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
This PMS is a non-interventional, prospective, single-arm, multi-center surveillance in accordance with Korean regulation, 'Standard for Re-Examination of New Drugs'.
- Trial name
- MCTSRPMS (NCT05048069)
- Testing
- Mucosta®SR Tablets 150mg(Rebamipide)
- Where
- South Korea
- Volunteers
- 600 people
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
This is a multicenter, double-blinded, double-dummy, active-controlled, randomized, Phase III clinical trial to evaluate the efficacy and safety of DA-6034 and to demonstrate the non-inferiority of DA-6034 compared with…
- Trial name
- NCT01813812
- Testing
- DA-6034, Rebamipide 300mg
- Where
- South Korea
- Volunteers
- 492 people
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
Gastritis Acute, Gastritis Chronic
Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis
- Trial name
- NCT06151210
- Testing
- DA-5219, Stillen® Tab
- Where
- South Korea
- Volunteers
- 467 people
- Sponsor
- Dong-A ST Co., Ltd.
Acute and Chronic Gastric Inflammation Patients
Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
The purpose of this study is to find optimum dosage of DW-3101 by evaluating efficacy and safety of each dosage group in Korean patients with acute and chronic gastric inflammation.
- Trial name
- NCT02386007
- Testing
- DW-3101_150mg, DW-3101_300mg, DW-3101_600mg
- Volunteers
- 60 people
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
Gastroenteritis, Gastritis
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Randomized, Placebo-Controlled, Phase 3 Trial of RHB-102 (BEKINDA) (Ondansetron 24 mg Bimodal Release Tablets) for Acute Gastroenteritis.
- Trial name
- GUARD (NCT02246439)
- Testing
- RHB-102
- Where
- 26 sites in United States
- Volunteers
- 330 people
- Sponsor
- RedHill Biopharma Limited
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of AD-203
This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab.
- Trial name
- NCT04066530
- Testing
- AD-203, Mucosta tab.
- Where
- South Korea
- Volunteers
- 475 people
- Sponsor
- Addpharma Inc.
Gastritis
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
The purpose of this study is to investigate the safety and clinical efficacy of HIP2101 in patients with acute or chronic gastritis.
- Trial name
- NCT05024721
- Testing
- HIP2101, RLD2101, HPP2101
- Where
- South Korea
- Volunteers
- 326 people
- Sponsor
- Hanmi Pharmaceutical Company Limited
Gastritis
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495
To Evaluate the Efficacy and Safety of CKD-495
- Trial name
- NCT04255589
- Testing
- CKD-495 75mg, Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg
- Where
- 17 sites in South Korea
- Volunteers
- 242 people
- Sponsor
- Chong Kun Dang Pharmaceutical
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of DA-5204
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the non-inferiority of DA-5204 compared with Stillen® tab.
- Trial name
- NCT02282670
- Testing
- DA-5204, Stillen tab.
- Where
- South Korea
- Volunteers
- 434 people
- Sponsor
- Dong-A ST Co., Ltd.
Gastritis
Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet
To Evaluate the Efficacy and Safety of CKD-495
- Trial name
- NCT03437785
- Testing
- CKD-495 75mg, CKD-495 150mg, Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg
- Where
- 16 sites in South Korea
- Volunteers
- 250 people
- Sponsor
- Chong Kun Dang Pharmaceutical